Tang Capital Management’s Kezar Life Sciences KZR Stock Holding History

Tang Capital Management’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-664,314	Closed	-$4.93M	–	52
2026 Q1	$4.93M	Hold	664,314	–	–	0.25%	38
2025 Q4	$4.18M	Sell	664,314 -55,686	-8%	-$325K	0.21%	60
2025 Q3	$2.81M	Hold	720,000	–	–	0.11%	113
2025 Q2	$3.3M	Hold	720,000	–	–	0.17%	105
2025 Q1	$3.51M	Hold	720,000	–	–	0.19%	93
2024 Q4	$4.84M	Buy	720,000 +355,970	+98%	+$2.65M	0.32%	72
2024 Q3	$2.81M	Buy	+364,030	New	+$2.2M	0.2%	90
2024 Q2	–	Sell	-68,894	Closed	-$621K	–	133
2024 Q1	$621K	Buy	68,894 +38,227	+125%	+$348K	0.06%	93
2023 Q4	$291K	Buy	+30,667	New	+$270K	0.03%	119

Tang Capital Management's KZR Position: Q2 2026 in Review

Tang Capital Management sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 664,314 shares — an estimated $4.93M sold.

Tang Capital Management first reported a position in KZR in Q4 2023 and held it in 9 quarters. The position peaked at $4.93M in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Tang Capital Management reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Tang Capital Management sold 664,314 Kezar Life Sciences shares in Q2 2026, an estimated $4.93M.
Tang Capital Management first reported a position in Kezar Life Sciences in Q4 2023 and held it in 9 quarters.
Tang Capital Management's Kezar Life Sciences position peaked at $4.93M in Q1 2026.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.